Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Waheed

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Blood Cancer Journal|March 26, 2016
Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)X Papanikolaou, A Rosenthal, M Dhodapkar, et al.
Leukemia|February 3, 2015
Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myelomaR Khan, S Apewokin, M Grazziutti, et al.
Leukemia|March 11, 2015
The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myelomaX Papanikolaou, D Alapat, A Rosenthal, et al.
Leukemia|April 18, 2012
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocolsS Z Usmani, B Nair, P Qu, et al.
Blood Cancer Journal|July 30, 2016
Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myelomaY Jethava, A Mitchell, M Zangari, et al.
Blood Cancer Journal|September 17, 2016
Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myelomaY Jethava, A Mitchell, M Zangari, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Blood Cancer Journal|March 26, 2016
Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)X Papanikolaou, A Rosenthal, M Dhodapkar, et al.
Leukemia|February 3, 2015
Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myelomaR Khan, S Apewokin, M Grazziutti, et al.
Leukemia|March 11, 2015
The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myelomaX Papanikolaou, D Alapat, A Rosenthal, et al.
Leukemia|April 18, 2012
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocolsS Z Usmani, B Nair, P Qu, et al.
Blood Cancer Journal|July 30, 2016
Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myelomaY Jethava, A Mitchell, M Zangari, et al.
Blood Cancer Journal|September 17, 2016
Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myelomaY Jethava, A Mitchell, M Zangari, et al.
Pageof 3